Literature DB >> 24596731

Pentoxifylline: a new armamentarium in diabetic foot ulcers.

Venkatesh Rewale1, Kiran Ravi Prabhakar2, Anjali M Chitale3.   

Abstract

BACKGROUND: Diabetic foot ulcers are estimated to affect 15% of all diabetics and precede almost 85% of foot amputations. Pentoxyfylline a substituted xanthenes' derivative has been reported to increase the blood flow to the microcirculation and enhances tissue oxygenation. It has been widely used in the treatment of intermittent claudication.
MATERIALS AND METHODS: Pentoxyfylline is known to decrease the rouleaux formation of RBC and hence helps in improving the microcirculation. Out of 67 patients 30 received pentoxyfylline and 32 were on traditional treatment and there was loss of follow-up in five cases. The response was observed subjectively, histologically and by Doppler studies.
RESULTS: It was observed that the patients on pentoxyfylline had early healing as compared to patients receiving only conventional treatment as evident on biopsy and Doppler.
CONCLUSION: Here in this research our objective was to determine whether pentoxyfylline (trental 400 mg) taken orally TDS in addition to ambulatory compression bandages and dressings improves the healing rates of diabetic ulcers.

Entities:  

Keywords:  Diabetic foot ulcers ligament; Doppler study; Pentoxyfylline

Year:  2014        PMID: 24596731      PMCID: PMC3939596          DOI: 10.7860/JCDR/2014/7856.3984

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

Review 1.  The changing scenario of the diabetes epidemic: implications for India.

Authors:  R Pradeepa; V Mohan
Journal:  Indian J Med Res       Date:  2002-10       Impact factor: 2.375

2.  Causes of venous ulceration: a new hypothesis.

Authors:  P D Coleridge Smith; P Thomas; J H Scurr; J A Dormandy
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

Review 3.  The diabetic foot: a global view.

Authors:  A J Boulton
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

4.  Pathways to diabetic limb amputation. Basis for prevention.

Authors:  R E Pecoraro; G E Reiber; E M Burgess
Journal:  Diabetes Care       Date:  1990-05       Impact factor: 19.112

Review 5.  Diabetic foot ulcers: current concepts.

Authors:  R G Frykberg
Journal:  J Foot Ankle Surg       Date:  1998 Sep-Oct       Impact factor: 1.286

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS.

Authors:  D Maroeska Te Loo; Nienke Bosma; Victor Van Hinsbergh; Paul Span; Rob De Waal; Ruud Clarijs; C Sweep; Leo Monnens; Lambertus Van Den Heuvel
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

8.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

9.  [Trental forte in leg ulcer therapy. Result of a field study].

Authors:  H Weitgasser; G Schmidt-Modrow
Journal:  Z Hautkr       Date:  1982-11-01

Review 10.  Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.

Authors:  J E Frampton; R N Brogden
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

View more
  1 in total

1.  Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Pamela Chen; Keryln Carville; Terry Swanson; Peter A Lazzarini; James Charles; Jane Cheney; Jenny Prentice
Journal:  J Foot Ankle Res       Date:  2022-05-25       Impact factor: 3.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.